Drugmakers propose EU pays half the costs of Covid jabs – RTE.ie
Pfizer and BioNTech are proposing that the European Union (EU) pays for half of the costs for Covid vaccines. This comes after some European countries, including Germany and France, abruptly halted the use of the AstraZeneca vaccine due to reports of rare blood clotting issues. As a result, Pfizer and BioNTech are offering the EU a deal that would see the bloc pay half the costs for each cancelled Covid vaccine dose. The Financial Times reports that this proposal aims to address concerns about the reliability of vaccine supplies and to ensure that the EU can meet its targets for vaccination.
